期刊文献+

人前列腺干细胞抗原的克隆及表达 被引量:4

Cloning and expression of human prostate stem cell antigen
原文传递
导出
摘要 目的克隆人前列腺干细胞抗原(PSCA)编码基因,并在大肠杆菌中表达PSCA蛋白.方法从培养的人前列腺癌细胞株中提取总RNA,反转录成cDNA,通过聚合酶链反应(PCR)方法扩增PSCA编码基因,克隆至pMD18-T载体,经DNA测序证实后亚克隆至谷胱甘肽巯基转移酶(GST)融合表达载体pGEX-5X-1,重组质粒转化大肠杆菌,异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达PSCA/GST融合蛋白.结果从培养的人前列腺癌细胞株中扩增出编码PSCA的cDNA(241 bp),序列测定证实与Genebank上登录的序列一致;成功构建了GST融合表达载体pGEX-5X-1/PSCA;表达了PSCA/GST融合蛋白(34.5×103).结论成功克隆了人PSCA基因,构建了GST融合表达载体并表达了PSCA/GST蛋白. Objective To clone the cDNA of human prostate stem cell antigen (PSCA) and ex- press the corresponding protein. Methods Total RNA was isolated from cultured human prostate cancer cell lines and mRNA was reversly transcribed into cDNA. Then PCR was used to amplify the PSCA cod- ing region. The PCR product was cloned into pMD18-T plasmid and sequenced, then subcloned into vec- tor pGEX-5X-1. The PSCA protein was expressed in E. coli of JM109 as fusion protein with glutathione S-transferase (GST) induced by IPTG. Results PSCA coding region (241 bp) was cloned into pMD18- T and the sequence was conformed; Fusion expressing vector of pGEX-5X-1/PSCA was successfully con- structed and correctly expressed PSCA/GST fusion protein (34. 5 ×10~3 ). Conclusion Human prostate stem cell antigen gene is successfully cloned and PSCA/GST fusion expressing vector is constructed. PSCA/GST fusion protein is correctly expressed in E. coli.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2003年第12期1100-1101,共2页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30271303)
  • 相关文献

同被引文献23

  • 1陈良冬,刘佳,李雁,庞代文,袁宏银,汤钊猷.量子点对肝癌细胞的免疫荧光成像作用[J].中华实验外科杂志,2006,23(9):1085-1087. 被引量:16
  • 2Heuff RF, Swift JL, Cramb DT. Fluorescence correlation spectroscopy using quantum dots: advances, challenges and opportunities. Chem Phys Chem,2007,9 : 1870-1880.
  • 3Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene ,2000,19 : 1288-1296.
  • 4Amara N,Palapttu GS, Schyuge M, et al. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res, 2001,61:4660-4665.
  • 5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57:43-66.
  • 6Reiter RE, Gu Z, Watabe T, et al. Prostate stem cell antigen: a cell surface marker ovcrexpressed in prostate cancer. Proc Natl Acad Sci USA, 1998, 95:1735-1740.
  • 7Matsueda S, Yao A, Ishihara Y, et al. A prostate stem cell antigen-derived peptide immunogenic in HLA-A24 prostate cancer patients. Prostate, 2004, 60:205-213.
  • 8LamJS, Yamashiro J, Shintaku IP, et al. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res, 2005, 11:2591-2596.
  • 9Gu Z, Yamashiro J, Kono E, et al, Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res, 2005, 65:9495-9500.
  • 10Chen HW, Lee YP, Chung YF, et al. Inducing long term survival with lasting anti-tumor immunity in treating B cell lymphoma bY a combined dendritic cell-based and hydrodynamic plasmid encoding IL-12 gene therapy. Int Immunol, 2003, 15:427-435.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部